A great outcome is one that lasts1.
HYDRUS® MICROSTENT VIDEOS
Paul Singh, MD: iOCT HYDRUS® MICROSTENT
IKE AHMED, MD: HYDRUS® PROVEN SAFETY
IKE AHMED, MD: THE HYDRUS® DIFFERENCE
IKE AHMED, MD: IOP ISN'T ENOUGH. PRESERVING A PATIENT'S VISION IS EVERYTHING.
References
1. Ahmed IIK, et al. Long-term outcomes from the HORIZON randomized trial for Schlemm’s Canal microstent in combination cataract and glaucoma surgery. Ophthalmology. 2022;129(7):742-751.
© 2024 Alcon Inc 06/24 US-HDM-2400073